Sinopharm Group Co. Ltd. SHTDY
Set alert
10.31 USD +0.14 +1.38%
At close · Oct 30
10.25 Day range 10.29
9.33 52-week range 14.06
- YTD
- -16.85%
- 1 year
- -17.45%
- Open
- 10.25
- Prev close
- 10.17
- Mkt cap
- 6.43B
- Vol
- 11.70K
- Avg vol
- 164.31K
- EPS
- 1.64
- P/E
- 6.29
More statistics
- Low
- 10.25
- High
- 10.29
1Y chart
Events in this range
- Apr 23, 2026Earnings: 0.829; estimate —; surprise —%
- Jun 24, 2026Dividend: 0.50255
Signals (44)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 5 days ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| RSI: Oversold | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| RSI: Oversold | Sep 15, 2026 | 1 month ago |
| RSI: Oversold | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 15, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 24, 2026 | 4 months ago |
| RSI: Oversold | Jun 24, 2026 | 4 months ago |
| RSI: Oversold | Jun 17, 2026 | 4 months ago |
| RSI: Oversold | Jun 9, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 3, 2026 | 5 months ago |
| RSI: Oversold | May 14, 2026 | 5 months ago |
| RSI: Oversold | May 8, 2026 | 5 months ago |
| RSI: Oversold | May 4, 2026 | 6 months ago |
| RSI: Oversold | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 22, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Apr 10, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| SMA: Bearish | Mar 18, 2026 | 7 months ago |
| SMA: Bullish | Mar 13, 2026 | 7 months ago |
| SMA: Bearish | Mar 11, 2026 | 7 months ago |
| SMA: Bullish | Mar 10, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 26, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 24, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 20, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 13, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 12, 2026 | 8 months ago |
| RSI: Overbought | Feb 6, 2026 | 8 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 6, 2026 | 9 months ago |
| SMA: Bearish | Dec 16, 2025 | 10 months ago |
| MACD: Sell Signal | Nov 20, 2025 | 11 months ago |
| RSI: Overbought | Nov 11, 2025 | 11 months ago |
Compare SHTDY
Chart and line up SHTDY against other symbols or a saved comparison set.
- SHTDY Sinopharm Group Co. Ltd.
10.31
+0.14 +1.38%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | SHTDY | SPY | QQQ |
|---|---|---|---|
| Last price | 10.31 | 755.72 | 690.49 |
| Change | +0.14 | -13.64 | -24.85 |
| Change % | +1.38% | -1.77% | -3.47% |
| Open | 10.25 | 761.38 | 697.13 |
| Day high | 10.29 | 761.46 | 698.63 |
| Day low | 10.25 | 750.36 | 683.45 |
| Previous close | 10.17 | 769.36 | 715.34 |
| Volume | 11.70K | 77.70M | 85.24M |
| Average volume | 164.31K | 41.22M | 34.57M |
| Market cap | 6.43B | 812.08B | 483.28B |
| P/E ratio | 6.29 | 23.99 | 26.44 |
| Earnings per share | 1.64 | 31.50 | 26.12 |
| Dividend yield | — | 0.00 | 0.00 |
| 52-week high | 14.06 | 779.09 | 759.66 |
| 52-week low | 9.33 | 631.97 | 558.28 |
| 1-week return | +5.74% | -0.559233% | -1.97% |
| 1-month return | +8.76% | -0.906075% | -6.66% |
| 3-month return | -7.78% | +1.89% | +1.02% |
| 6-month return | -12.92% | +5.16% | +3.41% |
| Year-to-date return | -16.85% | +10.82% | +12.40% |
| 1-year return | -17.45% | +11.16% | +10.29% |
| 2-year return | -17.06% | +32.90% | +42.71% |
| 50-day moving average | 9.77 | 767.63 | 725.41 |
| 200-day moving average | 11.48 | 728.53 | 679.17 |
| Target price | — | — | — |
| Beta | — | 0.00 | 0.00 |
| Short ratio | — | — | — |
| Institutional ownership | — | — | — |